Aurélie Courtin

SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.

Stéphanie Filleur, Aurélie Courtin, Slimane Ait‐Si‐Ali et al. · PubMed · 2003 · 254 citations

Immunology, Pathology, Cancer Biology +18

Death receptor pathways mediate targeted and non-targeted effects of ionizing radiations in breast cancer cells

Audrey Luce, Aurélie Courtin, Céline Levalois et al. · Carcinogenesis · 2009 · 68 citations · Full text

Estetrol is a weak estrogen antagonizing estradiol-dependent mammary gland proliferation

Catherine Gérard, Silvia Blacher, Laudine Communal et al. · Journal of Endocrinology · 2014 · 67 citations · Full text

Fragment-Based Discovery of a Potent, Orally Bioavailable Inhibitor That Modulates the Phosphorylation and Catalytic Activity of ERK1/2

Tom D. Heightman, Valério Berdini, Hannah Braithwaite et al. · Journal of Medicinal Chemistry · 2018 · 63 citations · Full text

Multiple Cancers, Tumor Biology, Medicinal Chemistry +22

Androgens Repress the Expression of the Angiogenesis Inhibitor Thrombospondin-1 in Normal and Neoplastic Prostate

Marc Colombel, Stéphanie Filleur, Carole Merle et al. · Cancer Research · 2005 · 62 citations · Full text